Wellington Pharmacy Limited - Accounts to registrar (filleted) - small 18.2

Wellington Pharmacy Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v22.1.4.3 08239118 Board of Directors Board of Directors 1.3.21 28.2.22 28.2.22 false true false false true false 'A' Ordinary 1.00000 'B' Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure082391182021-02-28082391182022-02-28082391182021-03-012022-02-28082391182020-02-29082391182020-03-012021-02-28082391182021-02-2808239118ns16:EnglandWales2021-03-012022-02-2808239118ns15:PoundSterling2021-03-012022-02-2808239118ns11:Director12021-03-012022-02-2808239118ns11:Director22021-03-012022-02-2808239118ns11:PrivateLimitedCompanyLtd2021-03-012022-02-2808239118ns11:SmallEntities2021-03-012022-02-2808239118ns11:AuditExempt-NoAccountantsReport2021-03-012022-02-2808239118ns11:SmallCompaniesRegimeForDirectorsReport2021-03-012022-02-2808239118ns11:SmallCompaniesRegimeForAccounts2021-03-012022-02-2808239118ns11:FullAccounts2021-03-012022-02-2808239118ns11:OrdinaryShareClass12021-03-012022-02-2808239118ns11:OrdinaryShareClass22021-03-012022-02-2808239118ns11:Director32021-03-012022-02-2808239118ns11:RegisteredOffice2021-03-012022-02-2808239118ns6:CurrentFinancialInstruments2022-02-2808239118ns6:CurrentFinancialInstruments2021-02-2808239118ns6:ShareCapital2022-02-2808239118ns6:ShareCapital2021-02-2808239118ns6:RetainedEarningsAccumulatedLosses2022-02-2808239118ns6:RetainedEarningsAccumulatedLosses2021-02-2808239118ns6:FurnitureFittings2021-03-012022-02-2808239118ns6:LandBuildings2021-02-2808239118ns6:FurnitureFittings2021-02-2808239118ns6:LandBuildings2021-03-012022-02-2808239118ns6:LandBuildings2022-02-2808239118ns6:FurnitureFittings2022-02-2808239118ns6:LandBuildings2021-02-2808239118ns6:FurnitureFittings2021-02-2808239118ns6:WithinOneYearns6:CurrentFinancialInstruments2022-02-2808239118ns6:WithinOneYearns6:CurrentFinancialInstruments2021-02-2808239118ns6:MoreThanFiveYears2022-02-2808239118ns6:MoreThanFiveYears2021-02-2808239118ns6:DeferredTaxation2021-02-2808239118ns6:DeferredTaxation2022-02-2808239118ns11:OrdinaryShareClass12022-02-2808239118ns11:OrdinaryShareClass22022-02-2808239118ns6:RetainedEarningsAccumulatedLosses2021-02-2808239118ns6:RetainedEarningsAccumulatedLosses2021-03-012022-02-28
REGISTERED NUMBER: 08239118 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2022

FOR

WELLINGTON PHARMACY LIMITED

WELLINGTON PHARMACY LIMITED (REGISTERED NUMBER: 08239118)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2022










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WELLINGTON PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 28 FEBRUARY 2022







DIRECTORS: J S Rahania
R Rahania
R K Saroy



REGISTERED OFFICE: 20 Coningsby Drive
Wolverhampton
West Midlands
WV2 2RN



REGISTERED NUMBER: 08239118 (England and Wales)



ACCOUNTANTS: Ashcrofts Accountants Limited
2 Cedargrove
Hagley
Stourbridge
West Midlands
DY9 0DR



BANKERS: Lloyds Bank plc
3 Queen Square
Wolverhampton
West Midlands
WV1 1RF

WELLINGTON PHARMACY LIMITED (REGISTERED NUMBER: 08239118)

BALANCE SHEET
28 FEBRUARY 2022

2022 2021
Notes £    £   
FIXED ASSETS
Tangible assets 4 162,973 195,826

CURRENT ASSETS
Stocks 5 84,544 71,963
Debtors 6 1,073,920 509,625
Cash at bank and in hand 985,091 144,053
2,143,555 725,641
CREDITORS
Amounts falling due within one year 7 (1,593,444 ) (616,351 )
NET CURRENT ASSETS 550,111 109,290
TOTAL ASSETS LESS CURRENT
LIABILITIES

713,084

305,116

PROVISIONS FOR LIABILITIES 9 (26,648 ) (32,891 )
NET ASSETS 686,436 272,225

CAPITAL AND RESERVES
Called up share capital 10 100 100
Retained earnings 11 686,336 272,125
SHAREHOLDERS' FUNDS 686,436 272,225

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WELLINGTON PHARMACY LIMITED (REGISTERED NUMBER: 08239118)

BALANCE SHEET - continued
28 FEBRUARY 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 November 2022 and were signed on its behalf by:




R K Saroy - Director



R Rahania - Director


WELLINGTON PHARMACY LIMITED (REGISTERED NUMBER: 08239118)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2022


1. STATUTORY INFORMATION

Wellington Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures, fittings & equipment - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

WELLINGTON PHARMACY LIMITED (REGISTERED NUMBER: 08239118)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2022


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2021 - 11 ) .

4. TANGIBLE FIXED ASSETS
Fixtures,
Freehold fittings
property & equipment Totals
£    £    £   
COST
At 1 March 2021 22,718 309,485 332,203
Additions - 1,940 1,940
At 28 February 2022 22,718 311,425 334,143
DEPRECIATION
At 1 March 2021 - 136,377 136,377
Charge for year - 34,793 34,793
At 28 February 2022 - 171,170 171,170
NET BOOK VALUE
At 28 February 2022 22,718 140,255 162,973
At 28 February 2021 22,718 173,108 195,826

5. STOCKS
2022 2021
£    £   
Stocks 84,544 71,963

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade debtors 909,891 329,442
Other debtors 92,995 71,738
Amounts owed by group undertakings - 39,139
VAT 65,150 62,261
Prepayments and accrued income 5,884 7,045
1,073,920 509,625

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade creditors 907,798 311,478
Amounts owed to group undertakings 794 -
Corporation tax 193,710 85,533
Social security and other taxes 3,170 2,796
Other creditors 140,252 213,842
Accruals and deferred income 347,720 2,702
1,593,444 616,351

WELLINGTON PHARMACY LIMITED (REGISTERED NUMBER: 08239118)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2022


8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2022 2021
£    £   
In more than five years 16,359 16,359

9. PROVISIONS FOR LIABILITIES
2022 2021
£    £   
Deferred tax 26,648 32,891

Deferred
tax
£   
Balance at 1 March 2021 32,891
Credited during the year (6,243 )
Balance at 28 February 2022 26,648

10. CALLED UP SHARE CAPITAL



Allotted, issued and fully paid:
Number: Class: Nominal 2022 2021
value: £    £   
50 'A' Ordinary £1 50 50
50 'B' Ordinary £1 50 50
100 100

11. RESERVES
Retained
earnings
£   

At 1 March 2021 272,125
Profit for the year 549,211
Dividends (135,000 )
At 28 February 2022 686,336

WELLINGTON PHARMACY LIMITED (REGISTERED NUMBER: 08239118)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 28 FEBRUARY 2022


12. RELATED PARTY DISCLOSURES

The company was under the control of Mr J S Rahania, Mr R Rahania and Mr R K Saroy throughout the current year and previous year as directors of the company and Nightchem Limited as the sole shareholder and immediate and ultimate holding company.

At 28 February 2022, there was a loan from Nightchem Limited of £794 (2021: £Nil). This unsecured loan is interest free and repayable on demand.

At 28 February 2022, there was a loan to Nightchem Limited of £Nil (2021: £39,139). This unsecured loan is interest free and repayable on demand.

At 28 February 2022, there was a loan to RJR Chem Ltd of £85,221 (2021: £70,379), a company in which Mr J S Rahania, Mr R Rahania and Mr R K Saroy are directors. This unsecured loan is interest free and repayable on demand.

At 28 February 2022, there was a loan to Church Street Healthcare Limited of £1,774 (2021: £1,359), a company in which Mr J S Rahania, Mr R Rahania and Mr R K Saroy are directors. This unsecured loan is interest free and repayable on demand.

At 28 February 2022, there was a loan from Daychem Ltd of £139,916 (2021: £139,916), a company in which Mr J S Rahania, Mr R Rahania and Mr R K Saroy are directors. This unsecured loan is interest free and repayable on demand.

13. ULTIMATE CONTROLLING PARTY

The ultimate parent company is Nightchem Limited, a company incorporated in England and Wales.